<?xml version="1.0" ?><ns2:com.thomsonreuters.ls.service.contract.soap.ontology.v1.OntologyDealSummaryOutput xmlns:ns2="local" id="136102"><Title>Ajinomoto to develop and market Dr Falk Pharma's budesonide enema in Japan for inflammatory bowel disease</Title><Principal>Dr Falk Pharma GmbH</Principal><Partner>Ajinomoto Co Inc</Partner><Type>Drug - Development/Commercialization License</Type><Status>Active</Status></ns2:com.thomsonreuters.ls.service.contract.soap.ontology.v1.OntologyDealSummaryOutput>